Cargando…

Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study

BACKGROUND: β-hydroxybutyrate (β-HB) and pyruvate have been associated with the brain energy utilization, which may play a role in the pathophysiology of schizophrenia. In this prospective study, we aim to investigate the trends of β-HB and pyruvate levels, metabolic changes, and cognitive function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yu-Chi, Lin, Pao-Yen, Lee, Yu, Hung, Chi-Fa, Hsu, Su-Ting, Wu, Chih-Ching, Wang, Liang-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865581/ https://www.ncbi.nlm.nih.gov/pubmed/29593413 http://dx.doi.org/10.2147/NDT.S157055

Ejemplares similares

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
por: Wang, Liang-Jen, et al.
Publicado: (2016)

Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
por: Huang, Kuan-Wei, et al.
Publicado: (2022)

Defining cognitive and functional profiles in schizophrenia and affective disorders
por: Huang, Yu-Chi, et al.
Publicado: (2020)

Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics
por: Lin, Ching-Hua, et al.
Publicado: (2019)

Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics
por: Lin, Ching-Hua, et al.
Publicado: (2022)

Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life
por: Chen, Chien-Yu, et al.
Publicado: (2018)

Defining cognitive profiles of depressive patients using the Brief Assessment of Cognition in Affective Disorders
por: Chen, Ruei-An, et al.
Publicado: (2019)

Differences in Psychiatric Comorbidities and Gender Distribution among Three Clusters of Personality Disorders: A Nationwide Population-Based Study
por: Hsu, Chih-Wei, et al.
Publicado: (2021)

β-hydroxybutyrate impairs bovine oocyte maturation via pyruvate dehydrogenase (PDH) associated energy metabolism abnormality
por: Zhang, Kai-Yan, et al.
Publicado: (2023)

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
por: Pae, Chi-Un
Publicado: (2020)

Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia
por: Yu, Chia-Ling, et al.
Publicado: (2023)

Antipsychotic medications and stroke in schizophrenia: A case-crossover study
por: Chen, Wen-Yin, et al.
Publicado: (2017)

Antipsychotic treatment and cognitive function in patients with schizophrenia
por: Tumova, M. A., et al.
Publicado: (2023)

Correction: Antipsychotic medications and stroke in schizophrenia: A case-crossover study
por: Chen, Wen-Yin, et al.
Publicado: (2019)

Association between Serum Lipids and Antipsychotic Response in Schizophrenia
por: Kim, David D., et al.
Publicado: (2019)

Month of birth and mental disorders: A population‐based study and validation using global meta‐analysis
por: Hsu, Chih‐Wei, et al.
Publicado: (2021)

The Morbidity and Associated Factors of Depression in Caregivers of Patients with Depressive Disorder
por: Lee, Yu, et al.
Publicado: (2023)

Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
por: Kucharska-Pietura, Katarzyna, et al.
Publicado: (2013)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia
por: Correia, Banny Silva Barbosa, et al.
Publicado: (2021)

Positive Symptoms in Antipsychotic-naïve Schizophrenia are Associated with Increased Body Mass Index after Treatment
por: Lin, Shih-Hsien, et al.
Publicado: (2021)

PM390. Comparison of Fast Versus Slow Strategy in Switching Schizophrenia Patients to Aripiprazole from Other Antipsychotics
por: Hwang, Tzung-Jeng, et al.
Publicado: (2016)

Bone Density in Chronic Schizophrenia with Long-Term Antipsychotic Treatment: Preliminary Study
por: Lee, Tae-Young, et al.
Publicado: (2010)

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
por: Liu-Seifert, Hong, et al.
Publicado: (2011)

Influence of Antipsychotic and Anticholinergic Loads on Cognitive Functions in Patients with Schizophrenia
por: Rehse, Michael, et al.
Publicado: (2016)

Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
por: Haddad, Chadia, et al.
Publicado: (2023)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
por: Blackman, Rachael K., et al.
Publicado: (2021)

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
por: Yu, Zhi-min, et al.
Publicado: (2019)

The Outcome of Antipsychotics-induced Tardive Syndromes: A Ten-year Follow-up Study
por: Chou, Pei-Chien, et al.
Publicado: (2023)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Grošić, Vladimir, et al.
Publicado: (2014)

Decreased IL-1ra and NCAM-1/CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment
por: Chu, Che-Sheng, et al.
Publicado: (2018)

Effect of Different Antipsychotic Drugs on Short-Term Mortality in Stroke Patients
por: Wang, Jen-Yu, et al.
Publicado: (2014)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

The Interplay between Vitamin D, Exposure of Anticholinergic Antipsychotics and Cognition in Schizophrenia
por: Gaebler, Arnim Johannes, et al.
Publicado: (2022)

Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer
por: Tseng, Wei-Ting, et al.
Publicado: (2019)

Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia
por: Kim, Jung-Jin, et al.
Publicado: (2021)

Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy
por: Zhang, Xiaobin, et al.
Publicado: (2020)

Chronic gamma-hydroxybutyric-acid use followed by gamma-hydroxybutyric-acid withdrawal mimic schizophrenia: a case report
por: Constantinides, Prometheas, et al.
Publicado: (2009)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
por: Kirino, Eiji
Publicado: (2017)

Comparison of prevalence and associated factors of depressive disorder between patients with head and neck cancer and those with lung cancer at a tertiary hospital in Taiwan: a cross-sectional study
por: Lee, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1mceveubjf003as80delqaujn4